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Acute tubulointerstitial nephritis associated with
aminonucleoside nephrosis
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of Minnesota Medical School, Minneapolis, Minnesota, USA
Acute tubulointerstitial nephritis associated with aminonucleoside ne-
phrosis. The aminonucleoside of puromycin (PAN) induces nephrotic
syndrome in rats. We studied the tubulointerstitial cellular (TIC)
infiltrate previously unrecognized in this model. Rats received one i.p.
injection of PAN (15 mg/100 g) and were sacrificed at 1, 3, 4, 5,7, 14,
20 and 28 days, Frozen kidney sections and peripheral blood cells were
stained with a panel of anti-rat monoclonal antibodies and quantitated
by epifluorescence microscopy. An increase in Ia cells (60/1000 TIC)(P < 0.001) and OX42 macrophages (MO) (18/1000 TIC) (P < 0.05)
were observed on day 5. On day 7 the inifitrate consisted of OX19
1-lymphocytes (29/1000 TIC) (P < 0.001) and OX42 MO (68/1000 TIC)(P < 0.001). The majority of the lymphocytes expressed the 0X8
cytotoxic T cell marker (23/1000 TIC) (P < 0.001). The severe mixed
cellular lesion present on day 14 was dominated by OX42 MO
(113/1000 TIC) (P < 0.001). With resolution of proteinuria on days 20
and 28, the infiltrate decreased, although OX42 MO persisted on day
28 (46/1000 TIC) (P < 0.001). The seventy of the cellular lesion
correlated with the degree of albuminuria (r = 0.57 to 0.81 for the
antibody panel). Expression of La antigens by proximal tubular epithe-
hal cells markedly decreased during peak proteinuria but normalized by
day 28. Increased deposition of C3 and IgG was not detected. Revers-
ible tubulointerstitial nephritis develops in PAN-treated rats and may be
a consequence of severe proteinuria.
Nephrotic syndrome induced in rats by the administration of
6-dimethylaminopurine-3-amino-D-ribose, the aminonucleoside
of puromycin (PAN) has served as an experimental model of
minimal lesion nephrotic syndrome since the initial report by
Frenk et a! [1] in 1955. The parent compound, puromycin, an
antibiotic isolated from Streptomyces alboniger, does not cause
the nephrotic syndrome when injected alone [21. The rat is
uniquely susceptible to the nephrotoxic actions of PAN. Milder
renal lesions have occasionally been observed in humans and
monkeys while guinea pigs, rabbits, dogs and mice appear to be
resistent to its nephrotoxic effects [3, 41.
The pathophysiological mechanism by which PAN produces
proteinuria remains uncertain although most of the evidence to
date favors the hypothesis that the glomerular epithelial cell is
the initial target of injury. It is clear that very brief exposure of
the kidney to PAN—as short as three minutes [51—is adequate
to lead to the development of nephrotic syndrome. Over the
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past decade, several studies designed to identify the basis of the
altered permeability of the glomerular capillary filter have
focused on the changes in the ultrastructure and function of the
glomerular epithelial cells and basement membrane [6—29]. The
initial reports of the nephrotoxicity of PAN included azotemia
associated with the nephrotic syndrome [1, 30, 311 and subse-
quent investigators have confirmed a reduced glomerular filtra-
tion rate (GFR) in both intact animals [22, 32, 33] and single
nephrons [21, 33, 34]. However, the presence of a decreased
GFR is not a typical finding in humans with minimal lesion
nephrotic syndrome and this finding has not been adequately
explained. It was initially suggested that renal blood flow might
be reduced as a result of diminished glomertilar capillary
luminal-area [6]. Micropuncture studies have demonstrated a
decrease in the glomerular capillary plasma flow-rate and the
ultrafiltration coefficient [21].
In the present study, we describe and characterize significant
changes in the renal interstitium which develop in rats given a
single intraperitoneal injection of PAN. Following the onset of
proteinuria, increasing numbers of mononuclear cells infiltrate
the interstitium reaching a peak on day 14 and declining
thereafter as the proteinuria subsides. There is significant
correlation between the number of interstitial cells and the
degree of albuminuria. These interstitial changes may account
for the decline in GFR observed in rats with PAN nephrosis.
Methods
Animals
Female Lewis rats weighing 85 to 140 g were purchased from
the Charles River Breeding Laboratories (Wilmington, Massa-
chusetts, USA).
Experimental design
Experimental animals received a single intraperitoneal injec-
tion of puromycin aminonucleoside (PAN) (Sigma Chemical
Company, St. Louis, Missouri, USA) 15 mg/100 g body weight
dissolved in normal saline. Control animals received a single
intraperitoneal injection of normal saline. Animals were fed
standard rat chow ad hibitum and given free access to water.
Groups of animals (5 PAN rats and 5 control rats) were
sacrificed at 1, 3, 4, 5, 7 and 14 days after receiving the
injection. An additional 4 PAN rats and 2 control rats were
sacrificed at 20 and 28 days.
14
Eddy and Michael: Interstitial nephritis in PAN nephrosis 15
Prior to the intraperitoneal injection and before sacrifice,
animals were housed individually in metabolic cages to obtain
24-hour collections of spontaneously voided urine.
At the time of sacrifice, animals were anaesthetized using
inhalation of ether or nitrous oxide and enflurane (Anaquest,
Pointe Claire, Quebec, Canada). Heparinized blood was ob-
tained by exsanguination via the abdominal aorta. Complete
exsanguination was established as previously described 1331.
The kidneys were immediately harvested, and pieces of renal
cortex were snap-frozen in isopentane precooled in liquid
nitrogen and stored at —70°C. Three kidneys from day 14 PAN
and control rats were placed in Zenker's fixative and processed
for routine light microscopy.
Also available were kidneys from Wistar rats, weighing 225 to
249 g, with chronic PAN-induced nephrosis which were from
Dr. L. Raij, The Veterans Administration Hospital, Minneapo-
lis, Minnesota, USA. Experimental rats (N = 3) received
weekly subcutaneous injections of PAN (2 mg/100 g body wt)
for the first three weeks and every other week thereafter.
Experimental and control rats (N = 3) also received colloidal
carbon (20 to 30 mg/l00 g body wt) once weekly at 4, 5, and 6
weeks. Animals were sacrificed at week 12 and the kidneys
harvested without prior perfusion or exsanguination.
Antibodies and antisera
A panel of monoclonal antibodies reactive with subsets of rat
lymphohemopoietic cells were obtained from Sera-Lab (distrib-
uted through Accurate Chemical and Scientific Corporation,
Westbury, New York, USA and Dimensions Laboratory, Mis-
sissauga, Ontario, Canada). The appropriate working dilution
for each antibody was established by titration on sections of
normal rat spleen. The pattern of reactivity of these antibodies
has been described previously [35] and is summarized as
follows: anti-Ia(0X4) reacts with B-lymphocytes and 3 to 9% of
peritoneal macrophages bearing MHC Class II surface antigens;
0X19 reacts with T-lymphocytes excluding natural killer cells
[36, 37]; W3/25 reacts with T-helper lymphocytes (70% of
peripheral T-cells) and 74% of peritoneal macrophages; 0X8
reacts with T-suppressor/cytotoxic lymphocytes (30% of pe-
ripheral T-lymphocytes) and natural killer cells [37]; and OX 1
anti-rat leukocyte common antigen (RCLA) reacts with all
marrow-derived leukocytes.
Monoclonal antibody 0X42 [381, which is reactive with the
C3bi receptor present on rat macrophages and granulocytes,
was from Dr. Alan Williams, MRC Cellular Immunology Unit,
Oxford, England.
Fluorescein-conjugated goat anti-mouse IgG F(ab')2 was pur-
chased from Tago, Inc., Burlingame, California and FITC-
conjugated rabbit anti-goat IgG F(ab')2 from Cooper Biomedi-
cal, West Chester, Pennsylvania, USA. FITC-conjugated anti-
serum was absorbed with normal rat plasma prior to use.
Kidney sections were also stained with FITC-conjugated goat
anti-rat C3 and FITC-conjugated rabbit anti-rat IgG (Cooper
Biomedical, West Chester, Pennsylvania, USA). The intensity
of staining for C3 and IgG was assessed using epifluorescence
microscopy. In addition, the integrity of the epithelial cells of
proximal tubules was evaluated by their reactivity with a panel
of FITC-conjugated lectins including wheat germ agglutinin
(triticum vulgaris), peanut agglutinin (arachis hypogaea), horse
gram agglutinin (dolichos biflorus) and concanavalin A (Vector
Laboratories, Burlingame, California, USA). The expression of
the FxIA antigen by proximal tubular epithelial cells was
assessed by indirect immunofluorescence staining using rabbit
antiserum to FxIA followed by FITC-conjugated goat anti-
rabbit IgG antiserum (Cooper Biomedical).
Enumeration of reactive tubulointerstitial cells
Sections (4 tm) of renal cortical tissue were stained with one
of the monoclonal antibodies OX42, anti-Ia, RCLA, OX19,
W3/25, or OX8 by indirect immunofluorescence using a dual
fluorochrome labeling technique as previously described [35].
In brief, in a three step sequence, acetone-fixed sections were
incubated with the appropriate dilutions of the monoclonal
antibody, FITC-conjugated rabbit anti-mouse IgG F(ab')2, and
finally FITC-conjugated goat anti-rabbit IgG F(ab')2. Coverslips
were mounted using PBS-glycerol containing 0.1% p-phenyl-
enediamine added to retard fluorescence quenching and the
nuclear stain ethidium bromide (1 ig!ml in PBS). For each of
the six monoclonal antibodies, a total of 27 interstitial fields
from each animal were selected for counting using a Zeiss
epifluorescence microscope and a 63X lens (Zeiss, Oberkochen,
FRG). Each section of renal cortex was divided into approxi-
mate upper, middle and lower third regions. Initially, one
glomerulus was randomly selected from each of the three
regions using phase contrast microscopy. Each field containing
the glomerulus then served as the central field of a 3 field by 3
field square. Each field was defined as the area enclosed within
a 10 mm x 10 mm eyepiece grid. Switching to epifluorescence
microscopy, the cells in each field were counted twice. Initially,
all positive tubulointerstitial (TI) cells—identified as the cells
with apple-green fluorescent membranes surrounding a red
nucleus—were counted. Caution was taken only to include
interstitial fluorescence clearly associated with a cell nucleus.
Secondly, all TI cell nuclei within the field—identified by the
red nuclear staining of ethidium bromide—were enumerated.
All cells within glomeruli and blood vessels, verified using
phase contrast microscopy, were carefully excluded from these
counts. After 27 fields had been evaluated, the results were
expressed as the number of positive cells per 1,000 TI cells
counted. An average of 2,646 TI cells were counted for each
antibody in each animal studied. The investigator was bliided
to the animal group at the time of counting. Results were
compared in a two-tailed analysis using Student's t-test for
independent means.
Urinary albumin excretion rates
Urinary albumin was quantitated by radial immunodiffusion
according to a modification of the technique of Mancini as
previously described [26]. The rabbit antiserum to rat albumin
was from Dr. T. Nevins, Department of Pediatrics, University
of Minnesota, USA. The timed urinary excretion of albumin
was calculated for individual animals and expressed as total
albumin normalized to a 24-hour collection period. Using linear
regression, the degree of albuminuria was correlated with the
mean tubulointerstitial cell counts obtained for each monoclo-
nat antibody.
Reactivity of peripheral blood mononuclear cells with
monoclonal antibodies
Peripheral blood mononuclear cells were isolated from hepa-
rinized blood by Ficoll-Hypaque density gradient centrifugation
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as previously described [39j with the following modifications:
the blood was diluted 1:3 with media 199 (Flow Laboratories,
McLean, Virginia, USA), a 13% Ficoll solution was used giving
the final Ficoll-Hypaque a specific gravity of 1.090 and gradi-
ents were centrifuged in 15 ml conical tubes using a ratio of
approximately 1 ml of Ficoll-Hypaque to 3 ml of the blood-
media mixture. Cells (1 x 106) in suspension were stained at 4°C
with each of the monoclonal antibodies using indirect immuno-
fluorescence and dual fluorochrome-labeled antibodies in a
three-step sequence identical to that employed for the kidney
sections as previously described 39J. Cell pellets were incu-
bated with 30 d of the appropriate working dilution for each
antibody. The percent positive cells was determined by count-
ing 200 random cells using epifluorescence microscopy. For this
study, blood was pooled from the S experimental or 5 control
animals sacrificed at each time period and thus results represent
the mean percent reactivity for each group of 5 animals.
Plasma creatinine determination
Aliquots of plasma obtained from blood pooled from groups
of experimental (N = 5) or control (N 5) animals sacrificed at
the same time were used to determine the serum creatinine
using a Beckman Creatinine Analyzer 2 (Beckman Instruments,
Fullerton, California, USA).
Results
Characterization of the interstitial cellular infiltrate
Rats given a single intraperitoneal injection of PAN devel-
oped immunohistochemical evidence of interstitial nephritis
which was first detected as a significant increase in the number
of Ia-positive cells (60/l000 TI cells) (P < 0.001) on day 5.
(Fig. lA). OX42 macrophages were only slightly increased to
18/1000 TI cells (P <0.05). On day 7, the interstitial infiltrate
was more pronounced and the cells were identified as T-
lymphocytes (OXl9 reactive cells, 29+11000 TI cells) (P <
0.001), the majority of which appeared to be T-cytotoxic/sup-
pressor cells (0X8 reactive cells, 23 +/1000 TI cells) (P =0.01),
and macrophages (OX42 reactive cells, 68+11000 TI cells) (P <
0.001). By day 14, the interstitial infiltrate reached its peak with
a mixed cellular lesion dominated by the presence of macro-
phages (OX42 reactive cells, 113+/1000 TI cells) (P < 0.001)
(Figs. I and 2). The interstitial nephritis was acute and revers-
ible as evidenced by the decline in the size of the infiltrate with
the resolution of proteinuria on days 20 and 28. However, even
on the 28th day after the injection of a single dose of PAN,
significant numbers of macrophages could be identified within
the interstitium (0X42 reactive, 46+/1000 TI cells (P < 0.001);
Ia reactive, 61+/1000 TI cells; P < 0.001). Examination of
kidney tissue from day 14 experimental animals processed for
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Fig. I. Mean number of cells per 1,000
tubulointerstitial (TI) cells reactive by indirect
immunofluorescence staining with monoclonal
antibodies anti-Ia (A), 0X42 (B), 0X19 (C),
0X8 (D), W3/25 (E) and RCLA (F) in rats
given a single i.p. injection of PAN. Results
for experimental animals (solid bars) represent
mean values + 1 SD. The shaded area
represents the mean 1 Sn for control
animals.
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Fig. 2. Immunofluorescence photomicrographs illustrating the renal interstitial infiltrate present in rats 14 days after PAN administration. In
comparison to normal rats (A) (x 310), the renal interstitium is infiltrated with mononuclear cells which express the macrophage surface marker
0X42 (B) (x230). Very few T-cytotoxic/suppressor cells are present in normal interstitium (C) (x270) compared to the numbers observed in day
14 PAN rats (D) (x 280). The W3/25 monoclonal antibody reactive with T-helper cells and a subpopulation of macrophages also reacts with
peritubular capillaries in normal renal interstitium (E) (< 280). A significant number of interstitial cells present in the day 14 infiltrate express the
W3/25 reactive epitope (F) (x300).
routine light microscopy demonstrated focal areas of mononu-
clear cell infiltrate within the interstitium (Fig. 3). However, use
of the immunohistochemical stains employing the panel of
monoclonal anti-rat cell antibodies proved to be a more sensi-
tive technique for appreciation of the severity of the interstitial
lesion.
An important technical point is worthy of comment. Several
of the monoclonal antibodies used in this study react with
components of the renal interstitium which appear not to be
associated with the surface membranes of cells. Monoclonal
antibody RCLA focally stains amorphous interstitial material
which at times appears to be associated with peritubular capil-
laries and W3/25 stains peritubular capillaries (Fig. 2E). A
nuclear stain was necessary to clearly identify that areas of
fluorescence were associated with interstitial cells.
Expression of ía antigens by proximal tubular epithelial cells
During these immunohistochemical studies, pronounced
changes in the expression of Ia antigens on proximal tubular
epithelial cells were observed. The cytoplasm of these cells
normally stains diffusely with monoclonal antibody 0X4 (anti-
Ia) (Fig. 4A). Reactivity was preserved on days 1, 3, and 4 and
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Fig. 3. Light photomicrographs illustrating the renal interstitium of normal eats (A) (x280) contrasting with the acute interstitial inflammatory
chgnges observed in rats 14 days after the injection of PAN (B) (X250).
Fig. 4. Immunofluorescence photomicrographs illustrating
the pattern of reactivity of anti-Ia monoclonal antibody with
the kidneys of rats with acute PAN nephrosis. A. Normal rat
kidneys show strOng reactivity of anti-Ia with proximal
tubular epithelial cells (x240). B. The kidneys of nephrotic
rats harvested 14 days following PAN injection show
decreased to absent staining of the epithelial cells of
proximal tubules. The interstitium has become invaded with
Ia positive mononuclear cells (x230). C. By 28 days post
PAN administration, La expression by proximal tubular
epithelial cells has almost fully recovered while the Ia
positive interstitial cells have markedly diminished in number
(x 190),
was normal to minimally decreased on day 5. However, by day
7 decreased reactivity was observed focally particularly in areas
associated with interstitial cellular infiltration. The reactivity
was greatly decreased on day 14 and frequently undetectable in
regions associated with severe interstitial nephritis (Fig. 4B).
Reactivity had partially recovered by day 20 and was almost
normal by day 28 (Fig. 4C).
The kidneys of proteinuric rats examined on days 7 and 14
following PAN administration showed normal reactivity with
the lectins concanavalin A (reactive with terminal mannose and
glucose), peanut agglutinin (reactive with galactose-N-acetylga-
lactosamine and galactose), horse gram agglutinin (reactive
with N-acetylgalactosamine) and anti-FxIA antiserum. The
kidneys of day 14 PAN rats showed slightly decreased staining
along the luminal surface of proximal tubular epithelial cells
with wheat germ agglutinin (sialic acid and N-acetylglucos-
amine reactive).
Relationship between severity of the interstitial infiltrate and
rena/functional parameters
The severity of the interstitial nephritis correlated with the
degree of albuminuria (Table 1). As summarized in Table 2,
there was significant positive correlation between the 24-hour
urinary albumin excretion and the average number of tubuloin-
terstitial cells reactive with each monoclonal antibody (r = 0.57
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Table 1. Urinary albumin excretion following the injection of
puromycin aminonucleoside
Day post-
injection
N
animals
24 hour
albuminuria
mean SD Range
1 5 0.6 1.1 mg 0.05—2.5 mg
3 5 0.8 0.6 0.5—1.6
4 5 40.0 16.6 21—64
5 5 270 256 112—724
7 5 454 119 279—566
14 5 694 228 422—1043
20 4 120.2 12.7 106—136
28 4 3.1 2.2 0.9—6.2
Controls 31 0.38 0.8 0—4.2
Table 2. Correlation between positive TI cells and albumin excretion
ratesa
Antibody-
reactive cells
Correlation
coefficient P value
0X42 0.81 <0.001
0X8 0.75 <0.001
0X19 0.67 <0.001
W3/25 0.67 <0.001
anti-Ia (0X4) 0.66 <0.001
RCLA (OXI) 0.57 0.001
Correlation based on the results obtained for 32 animals with PAN-
induced nephrosis sacrificed on days 1, 3, 4, 5, 7, 14, or 28
Table 3. Blood mononuclear cells during PAN-induced nephrosisa
Monoclonal antibody
Days post-
injection Group
(% positive cells) bTotal cells per
ml blood X 10OXl9 W3/25 0X8 Ia
I PAN
Control
49
54
47 13
36 23
23
14
3.4
2.8
3 PAN
Control
N/AC
N/A
37 13
38 13
21
22
4.3
4.0
4 PAN
Control
47
44
34 14
33 12
19
26
3.4
4.9
5 PAN
Control
47
42
28 12
42 20
18
18
2.8
3.4
7 PAN
Control
47
48
47 19
38 17
21
28
N/A
4.7
14 PAN
Control
49
55
33 18
43 19
17
23
4.0
3.8
Control (N = 19)d 49 7.9 38.9 9.4 20.3 4.9 25.4 5.3 N/A
C Table illustrating percentage of peripheral blood interphase cells reactive with the indicated monoclonal antibody using indirect immunofluo-
rescence employing two fluorochrome labeled antibodies (F(ab')2 fragments). Results represent the mean number of positive cells using blood
pooled from 5 animals.
b Yield of mononuclear cells by Ficoll-Hypaque (S.G. = 1.090) centrifugation
C N/A = Not available
"Controls (mean SD) for a larger population of female Lewis rats weighing 78 to 136 g studied following completion of the present study
provide larger reference values.
to 0.81). The mean serum creatinine (pooled from 5 animals)
remained constant at 0.3 mg/dl in control animals on days 3, 4,
5, 7, and 14, whereas the mean serum creatinine in experimental
animals was 0.4, 0.5, 0.5, 0.8, and 0.8 mg!dl on these respective
days. Despite the fact that the degree of albuminuria increased
progressively until day 14, the volume (24 hr) of spontaneously
voided urine also increased reaching a mean of 19.2 ml (range
8.0 to 32.1 ml) on day 7 (P <0.001) and 21.0 ml (range 8.3 to
37.5 ml) on day 14 (P < 0.001) compared with a mean control
value of 5.9 ml (range 1.7 to 14.0 ml).
Absence of deposition of complement and immuno globulin G
C3 was detected along cortical tubular basement membranes
in a focal, interrupted linear pattern in normal female Lewis
rats. During the course of acute PAN-induced nephrosis, a
further increase in staining of the tubulointerstitial compart-
ment was not appreciated except for reactivity with protein
reabsorption droplets and tubular casts. There was diffuse
staining of the interstitium of normal rats with anti-rat IgG
antiserum. The intensity of this staining actually decreased on
days 1 through 20 of acute PAN-induced nephrosis but ap-
proached normal levels by day 28. Rare positive interstitial cells
reactive with anti-IgG were appreciated on day 14.
Peripheral blood mononuclear cell subsets
The administration of PAN had no detectable effect on either
the total number of circulating mononuclear cells or the percent
of cells reactive with each of the monoclonal antibodies tested
(Table 3). Monoclonal antibody 0X42 was not available at the
time of these studies.
Chronic PAN nephrosis
Rats with chronic PAN-induced nephrosis produced by seven
subcutaneous injections had marked interstitial nephritis at 12
weeks associated with significant albuminuria (480 122 mg/24
hours versus 8.3 4 mg!24 h in the control animals). There was
a marked increase in all subclasses of mononuclear cells with
macrophages representing the dominant cell type (Fig. 5). An
attempt had not been made to remove circulating lymphohemo-
poetic cells by complete exsanguination prior to harvesting
these kidneys accounting for the higher background counts in
the control animals. However, the relative increase in the
number of interstitial cells was strikingly similar to that ob-
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Fig. 5. Cell surface markers characterizing the mononuclear intersti-
tial cell infiltrate present at 12 weeks in rats with chronic PAN
nephrosis. Results represent the mean number of positive cells per
1,000 tubulointerstjtjal (TI) cells and are expressed as mean + 1 SD. The
absence of SD bars for some of the control counts indicates that these
values were too small to be illustrated.
served in the day 14 acute PAN animals. For the acute (day 14)
compared with chronic (week 12) nephrotic rats, the relative
increase over normal in 0X42 positive tubulointerstitial cells
was 12x versus 11.5x; Ia positive cells was 5.6x versus 5.9x;
RCLA 3.2x versus 4.2x; 0X19 6.3x versus 5,9x; W3/25 3.9x
versus 4.2x and 0X8 3.4x versus 3.9x.
Discussion
Associated with the development of acute nephrotic Syn-
drome, PAN-injected rats develop impressive tubulointerstitial
nephritis which has not previously been recognized except in a
recent report by Rossman et a! [401 who observed an increased
number of interstitial mononuclear cells thought to be primarily
natural killer cells (OX8, 0X19).
In the present studies, interstitial nephritis is first detectable
on day 5, the earliest change being an increase in Ia positive
cells, some of which bear the 0X42 macrophage marker. This
change may represent a proliferation of cortical interstitial
dendritic cells and/or an influx of macrophages from the circu-
lation. The infiltrate develops after the onset of significant
proteinuria on day 3 and is reversible as proteinuria decreases
on days 20 and 28. There is a significant correlation between
quantitative albuminuria and the number of interstitial mono-
nuclear cells present.
The early interstitial lesion of day 7 is characterized by an
increase in macrophages and T-lymphocytes (OX 19 positive),
the majority of which appear to be T-cytotoxic/suppressor cells
(0X8 positive). It was not possible to differentiate the presence
of natural killer cells (OX8, 0X19) in the present study since
the OXl9 and 0X8 reactive cells increased in parallel, with the
former always outnumbering the latter. The interstitial nephritis
appears to peak at day 14 with a mixed cellular lesion containing
increased numbers of all subsets of lymphohemopoietic cells,
the most dominant one being the macrophage. The infiltration
of mononuclear cells into the interstitium is associated with loss
of MHC class II (Ia) antigens from the epithelial cells of
proximal tubules. In addition, this lesion is temporally associ-
ated with abnormalities in renal function including an elevation
in serum creatinine and polyuria.
Rats with chronic-PAN nephrotic syndrome induced by
repeated subcutaneous injections develop severe interstitial
nephritis by 12 weeks, the cellular composition of which closely
resembles the acute lesion observed at day 14 based on the
surface marker profile of the mononuclear cells present in the
interstitial infiltrate.
The pathogenic mechanism responsible for the development
of the cellular infiltrate is not clear. Increased deposition of
immunoglobulin 0 and C3 were not observed except in tubular
casts, suggesting that complement and humoral immune mech-
anisms are not significant in this model.
We speculate that two alternative mechanisms might trigger
the interstitial changes observed. Interstitial nephritis may be a
consequence of tubular epithelial cell injury induced by PAN in
a manner analogous to that described for epithelial cells of
glomerular origin [4, 27, 281. Reactive oxygen metabolites are
one potential mediator of injury in PAN-induced nephrosjs,
This has been suggested on the basis that hypoxanthine, a
substrate for superoxide anion production, is an intermediate
metabolite of PAN [41]. The striking decrease in the expression
of Ia antigens by the epithelial cells of proximal tubules ob-
served during the course of PAN nephrosis might result from
such cellular injury. However, the results of our lectin binding
studies suggested that tubular damage was not extensive and it
is possible that the loss of Ia antigens was a consequence of
other factors, such as a unique cellular immune response or the
reabsorption of filtered protein. Although the role of Ia mole-
cules expressed on nonlymphoid cells is unknown, it has been
suggested that those associated with epithelial cells might
function in an immunological context, handling antigens at
mucosal surfaces [42—46], Morphologic studies suggest that Ia
antigens are associated with phagolysosomes of renal tubular
epithelial cells—the site of accumulation of macromolecules
during proteinuria.
The second proposed mechanism is based on the correlation
between the quantity of urinary albumin and the intensity of the
interstitial infiltrate observed in this study which suggests the
possibility of a cause and effect relationship. The precise
mechanism by which proteinurla might initiate interstitial ne-
phritis is unknown. An intriguing possibility is that it represents
a cellular immune response to antigenic components reab-
sorbed from the glomerular filtrate and derived either from the
plasma or components of the glomerular capillary wall. The
recognition of hidden antigenic determinants in basement mem-
branes and the possibility of creation of new epitopes during
reabsorption of macromolecules provide a theoretical basis for
this hypothesis. Alternatively, interstitial inflammation may
represent a response to tubulointerstitial injury induced during
proteinuria. It has been suggested that the excessive concen-
tration of absorbed proteins appearing within the lysosomes of
proximal tubular epithelial cells during proteinuria may lead to
cellular damage, possibly due to the leakage of lysosomal
enzymes into the cytosol [47].
If cellular events occurring in the interstitium are a conse-
quence of proteinuria, then these changes should be present in
other experimental models of proteinuria. Unfortunately, in the
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majority of these models, the histopathology of the interstitium
has not yet been investigated in any detail. However, in the
model of adriamycin nephrosis, pathologic changes in the
interstitium are prominent [48—53]. We examined kidneys from
proteinuric rats 24 days following a single intravenous injection
of adriamycin (7.5 mg/kg) (provided by Dr. T. Wells and Dr.
A.F. Michael, University of Minnesota) and found an intersti-
tial infiltrate dominated by OX42 macrophages (4.9x in-
crease) with a smaller population of OX8 cytotoxic T-lymph-
ocytes (2.8x increase) (unpublished observations). Rats de-
velop proteinuria associated with focal glomerular sclerosis
following 5/6 nephrectomy (remnant kidney model). Tubulointer-
stitial changes become increasingly pronounced with time and
cell surface marker studies have characterized the cellular
lesion as consisting predominantly of W3/25+ and Ia+ cells
[54].
From the data available on humans with chronic glomerulo-
nephritis, severe proteinuria [55—76] and significant tubulointer-
stitial injury [77—82] are predictive of progressive renal failure
but the relationship between these variables has rarely been
examined [83, 84]. Progressive renal failure is universally
associated with severe pathologic changes in the interstitium
[77] and yet there is no clear understanding of the pathophysi-
ologic basis of these changes. In the absence of known media-
tors of tubulointerstitial inflammation such as infection or
tubular toxins, the interstitial pathology has often been ex-
plained on the basis of ischemic damage due to the obliteration
of the peritubular capillary plexus following sclerosis of the
glomerular tuft [85]. The results of the present study suggest
that, under the appropriate conditions, chronic proteinuria may
be another important factor in the genesis of tubulointerstitial
damage. The outstanding exception of minimal lesion nephrotic
syndrome in which highly selective proteinuria restricted to the
loss of low molecular weight proteins is not associated with
interstitial inflammation highlights the need for additional stud-
ies in order to identify the precise nature of this relationship.
In summary, in this study we report the development of acute
interstitial nephritis during the course of nephrotic syndrome in
PAN-treated rats. The intensity of the interstitial infiltrate
correlates with the severity of proteinuria, reverses as the
proteinuria subsides and may account for the decline in GFR
previously unexplained in this model. Detailed analysis of cell
surface markers suggests that the earliest detectable change is
an increase in Ia-positive interstitial cells, followed by the
activation of cytotoxic T-lymphocytes and finally the recruit-
ment of a mixed mononuclear cell population, and macrophages
in particular, as the interstitial lesion reaches its peak on day 14.
Future studies are required to establish the mechanisms in-
volved in the development of this tubulointerstitial lesion.
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